Atlas Trials

Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.

Clinical trial NCT06043193 · RECRUITING

Trial details

NCT number
NCT06043193
Sponsor
Hospices Civils de Lyon
Status
RECRUITING
Study type
OBSERVATIONAL
Metastatic Neuroendocrine Tumour
Start date
2024-02-20
Primary completion
2025-03-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.